Advances in biotechnology, or “technology that applies to and/or is enabled by life sciences innovation or product development” (National Institute of Standards and Technology, 2022), present vast ...

The industry contributes $50 billion to the state GDP, and employs 130,000 people across research and manufacturing.

Like other commissions set up by Congress—such as the Cyberspace Solarium Commission that provided crucial cybersecurity measures—the National Security Commission on Emerging Biotechnology (NSCEB) was ...

We’re tackling biotechnology this month, a technology area with which AFCEA isn’t traditionally aligned. But we see a developing synergy between this burgeoning discipline and national security and ...

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services. By submitting this information, I agree to the privacy policy and to learn more about ...

In trading on Friday, biotechnology shares were relative leaders, up on the day by about 2.5%. Leading the group were shares of Inozyme Pharma, up about 177.5% and shares of Emergent BioSolutions up ...

In trading on Wednesday, biotechnology shares were relative laggards, down on the day by about 2.7%. Helping drag down the group were shares of REGENXBIO, off about 17% and shares of Forte Biosciences ...

Congress established the National Security Commission on Emerging Biotechnology (NSCEB) in the Fiscal Year 2022 National Defense Authorization Act “to examine and make recommendations with respect to ...